المؤلفون: Selivanov SP, Barysheva EV, Kovalik TA, Isaeva SN, Petlin AV

المصدر: Urologiia (Moscow, Russia : 1999) [Urologiia] 2012 May-Jun (3), pp. 47-50.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: Medit︠s︡ina Country of Publication: Russia (Federation) NLM ID: 100900900 Publication Model: Print Cited Medium: Print ISSN: 1728-2985 (Print) Linking ISSN: 17282985 NLM ISO Abbreviation: Urologiia Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Hormonal/*administration & dosage , Flutamide/*administration & dosage , Goserelin/*administration & dosage , Prostatic Neoplasms/*drug therapy , Prostatic Neoplasms/*pathology, Aged ; Humans ; Male

المؤلفون: Davydova NA, Dmitrieva AI, Selivanov SP, Tkachenko SB, Kovalik TA, Kolomiets SA, Sevast'ianova NV, Novitskiĭ VV

المصدر: Urologiia (Moscow, Russia : 1999) [Urologiia] 2008 Mar-Apr (2), pp. 26-9.

نوع المنشور: English Abstract; Journal Article

بيانات الدورية: Publisher: Medit︠s︡ina Country of Publication: Russia (Federation) NLM ID: 100900900 Publication Model: Print Cited Medium: Print ISSN: 1728-2985 (Print) Linking ISSN: 17282985 NLM ISO Abbreviation: Urologiia Subsets: MEDLINE

مواضيع طبية MeSH: Mutation* , Polymorphism, Genetic*, Glutathione S-Transferase pi/*genetics , Glutathione Transferase/*genetics , Neoplasm Proteins/*genetics , Prostatic Neoplasms/*genetics, Aged ; Aged, 80 and over ; Genotype ; Glutathione S-Transferase pi/metabolism ; Glutathione Transferase/metabolism ; Humans ; Male ; Middle Aged ; Neoplasm Proteins/metabolism ; Prostatic Neoplasms/enzymology

المؤلفون: Selivanov SP, Isaeva SN, Kovalik TA, Chén' MN, Aleksandrovich IN, Kaliev EA

المصدر: Urologiia (Moscow, Russia : 1999) [Urologiia] 2007 Nov-Dec (6), pp. 52-5.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: Medit︠s︡ina Country of Publication: Russia (Federation) NLM ID: 100900900 Publication Model: Print Cited Medium: Print ISSN: 1728-2985 (Print) Linking ISSN: 17282985 NLM ISO Abbreviation: Urologiia Subsets: MEDLINE

مواضيع طبية MeSH: Neoadjuvant Therapy*, Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Carcinoma, Transitional Cell/*drug therapy , Urinary Bladder Neoplasms/*drug therapy, Aged ; Antimetabolites, Antineoplastic/administration & dosage ; Antimetabolites, Antineoplastic/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carcinoma, Transitional Cell/diagnostic imaging ; Carcinoma, Transitional Cell/mortality ; Deoxycytidine/administration & dosage ; Deoxycytidine/adverse effects ; Deoxycytidine/analogs & derivatives ; Disease-Free Survival ; Drug Hypersensitivity/mortality ; Female ; Humans ; Leukopenia/chemically induced ; Leukopenia/mortality ; Male ; Middle Aged ; Neoplasm Invasiveness ; Organoplatinum Compounds/administration & dosage ; Organoplatinum Compounds/adverse effects ; Oxaliplatin ; Radiography ; Survival Rate ; Time Factors ; Urinary Bladder Neoplasms/diagnostic imaging ; Urinary Bladder Neoplasms/mortality ; Gemcitabine